GlassScriptPhysician profile
Heather Ballantyne
NPI 1619532876
$1,325.24
in general payments reported to CMS, 2019-2025
15 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $161 · 2022: $183 · 2023: $457 · 2024: $403 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $966 · Education: $16.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $965.97 |
| Education | $16.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $354.24 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $145.72 | 2023-2024 | Dutoprol |
| Janssen Pharmaceuticals, INC | $141.00 | 2022-2023 | Xarelto |
| Pfizer INC. | $139.94 | 2022-2024 | |
| Medtronic, INC. | $132.13 | 2024 | Na |
| Boehringer Ingelheim Pharmaceuticals, INC. | $117.98 | 2023 | Jardiance |
| Heartflow, INC. | $57.70 | 2025 | |
| Impulse Dynamics (USA) INC. | $57.13 | 2023 | Optimizer |
| Lantheus Medical Imaging, INC. | $55.36 | 2023 | Definity |
| Cvrx, INC. | $27.05 | 2023 | Barostim Neo System |
| Boston Scientific Corporation | $23.80 | 2025 | Latitude Communicator Power Supply |
| Ge Healthcare | $21.63 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $18.92 | 2024 | Camzyos |
| Amgen INC. | $18.71 | 2025 | Repatha |
| Irhythm Technologies, INC. | $13.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Ballantyne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.